BCG July 18, 2024
By Torben Danger

Headquartered in Cambridge, Massachusetts, Biogen is a global biotechnology company that has pioneered innovative therapies for multiple sclerosis, spinal muscular dystrophy, and Alzheimer’s disease. Chief Financial Officer Mike McDonnell sat down with BCG’s Torben Danger to discuss Fit for Growth, the company’s bold transformation initiative, and employees’ role in making it a success. The discussion also touched on leadership, inorganic growth, and AI. Edited excerpts of the conversation follow.

Biogen CFO Mike McDonnell on the leadership lessons he learned from his roles across different industries.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Interview / Q&A, Pharma / Biotech, Trends
New 'how-to guide' for future rapid vaccine development
Medicare prescription drug pricing variance: 5 things to know
Sanofi adds new $600M manufacturing plant
Biden administration pushes anti-obesity drug pressure to Trump
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?

Share This Article